Copyright
©The Author(s) 2016.
World J Nephrol. Nov 6, 2016; 5(6): 531-537
Published online Nov 6, 2016. doi: 10.5527/wjn.v5.i6.531
Published online Nov 6, 2016. doi: 10.5527/wjn.v5.i6.531
Table 1 Demographic of patients
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
Age (yr) | 17 | 38 | 45 | 40 | 25 | 45 |
Gender | Male | Male | Male | Male | Male | Male |
Original disease | CGN | HT | HT | ADPKD | HT | DM |
ABO group | A | B | AB | AB | B | A |
Dialysis | 12 mo | 8 mo | 7 mo | 18 mo | 7 mo | 3 mo |
Weight (kg) | 40 | 44 | 59 | 68 | 43 | 55 |
Original donor relation | Father | Wife | Wife | Wife | Mother | Wife |
Reason for joining KPD | ||||||
Sensitized | Yes | Yes | Yes | Yes | Yes | No |
ABO incompatible | Yes | |||||
Time from KPD registration to find donor | 2 wk | 1 d | 2 wk | 6 mo | 4 wk | 1 mo |
Time from donor to KT | 58 d | 60 d | 55 d | 75 d | 48 d | 60 d |
With original donor | ||||||
LCM (%) | 80/80/90 | 5/5/7 | 5/0/5 | 80/80/90 | 12/7/25 | |
FCM (MCS) | 260/298 | Neg/236 | 80/159 | 150/250 | N/N | |
DSA class 1 (MFI) | A1 = 8000 | No DSA | B44 = 4188 | A11 = 10000 | BW4 = 5000 | |
B57 = 6200 | A31 = 1100 | B57 = 12645 | ||||
BW4 = 12645 | ||||||
DSA class 2 (MFI) | DQ7 = 1600, DQ9 = 2200 | DQ2 = 9000 | No DSA | No DSA | DR13 = 7000 | |
With cross donor | ||||||
LCM (%) | Neg/neg/neg | 15/15/20 | Neg/neg | Neg/Neg/Neg | 5/12/2010 | Neg/Neg/Neg |
FCM (MCS) | Neg/neg | Neg/200 | Neg/neg | Neg/Neg | Neg/Neg | Neg/Neg |
DSA class 1 | No DSA | No DSA | No DSA | No DSA | No DSA | No DSA |
DSA class 2 | No DSA | No DSA | No DSA | No DSA | No DSA | No DSA |
Desensitization | Yes | Yes | Yes | No | No | No |
State | Gujarat | Rajasthan | Gujarat | Gujarat | Rajasthan | Rajasthan |
Table 2 Desensitisation protocol and outcome
Patient 1 | Patient 2 | Patient 3 | |
Before desensitization with original donor | |||
LCM/DTT/AHG (%) | 80/80/90 | 5/5/7 | 5/0/5 |
T/B FCM (MCS) | 260/298 | Neg/236 | 80/159 |
DSA class 1 | A1 = 8000, B57 = 6200 | No DSA | B44 = 4188, A31 1100 |
DSA class 2 | DQ7 = 1600, DQ9 = 2200 | DQ2 = 9000 | No DSA |
DP | 8TPE + 8Bort/MP/IVIG + TAC/MMF | 9TPE + 6Bort/MP/IVIG + R + TAC/MMF | 4TPE + 4Bort/MP/IVIG + TAC/MMF |
After desensitization with original donor | |||
LCM | 80/80/90 | 17/15/20 | 5/0/7 |
FCM | 254/333 | Neg/504 | Neg/129 |
DSA class 1 | A1 = 2000, B57 = 5500 | No DSA | B44 = 4622, A31 = 1400 |
DSA class 2 | DQ7 = 2000, DQ9 = 2000 | DQ2 = 12000 | No DSA |
Side effects | Tuberculosis | Graft nephrectomy | Tuberculosis |
Table 3 Human leukocyte antigen data of patients and donors
A | B | Bw | Cw | DR B1 | DR B3,4,5 | DQ B1 | ||||||||
P1 | 2 | 29 | 44 | - | 4 | - | 7 | 15 | 4 | 15 | 51 | 53 | 4 | 6 |
D1 | 1 | 29 | 44 | 57 | 4 | - | 6 | 15 | 7 | 15 | 51 | 53 | 6 | 9 |
P2 | 2 | 33 | 40 | 44 | 4 | 6 | 7 | 15 | 10 | 15 | 51 | - | 5 | 6 |
D2 | 33 | - | 8 | 58 | 4 | 6 | 3 | 7 | 17 | - | 52 | - | 2 | - |
P3 | 2 | 11 | 35 | 52 | 4 | 6 | 12 | - | 4 | 15 | 51 | 53 | 6 | 8 |
D3 | 31 | 33 | 44 | 52 | 4 | - | 7 | 12 | 4 | 15 | 51 | 53 | 6 | 8 |
P4 | 24 | 32 | 18 | 35 | 6 | - | 4 | 7 | 11 | 15 | 51 | 52 | 6 | 7 |
D4 | 11 | 32 | 8 | 57 | 4 | 6 | 6 | 7 | 13 | 15 | 51 | 52 | 6 | - |
P5 | 24 | 33 | 8 | 35 | 6 | - | 4 | 7 | 17 | - | 52 | - | 2 | - |
D5 | 24 | 32 | 8 | 49 | 4 | 6 | 7 | - | 13 | 17 | 52 | - | 2 | 6 |
P6 | 11 | 24 | 13 | 56 | 4 | 6 | 3 | 4 | 15 | 17 | 51 | 52 | 2 | 5 |
D6 | 1 | 68 | 75 | 70 | 6 | 0 | 7 | 8 | 10 | 11 | 52 | 0 | 5 | 7 |
Table 4 Demographic of donor data
Donor 1 | Donor 2 | Donor 3 | Donor 4 | Donor 5 | Donor 6 | |
Age (yr) | 46 | 38 | 40 | 38 | 45 | 35 |
Gender | Male | Female | Female | Female | Female | Female |
Weight (kg) | 44 | 50 | 50 | 50 | 60 | 82 |
ABO group | A1 | B | A | B | B | B |
GFR (R/L) | 54/61 | 50/50 | 47/55 | 55/55 | 56/50 | 52/49 |
Creatinine (mg/dL) | 0.8 | 0.7 | 0.5 | 0.6 | 0.6 | 0.8 |
Renal vessel (R/L) | 2A2V/1A1V | 1A1V/1A1V | 1A1V/1A1V | 1A1V/2A1V | 1A2V/1A1V | 1A1V/1A1V |
LDN side | L | L | L | L | L | L |
Table 5 Surgical details and outcome
Patient | 1 | 2 | 3 | 4 | 5 | 6 |
WIT (s) | 113 | 120 | 137 | 97 | 136 | 85 |
CIT (min) | 50 | 150 | 85 | 136 | 73 | 60 |
AT (min) | 31 | 27 | 24 | 40 | 25 | 14 |
UO (mL) | 1100 | 1200 | 600 | 700 | 1000 | 950 |
Robotic KT | Yes | Yes | Yes | |||
Open KT | Yes | Yes | Yes | |||
LDN | Yes | Yes | Yes | Yes | Yes | Yes |
KT date (2015) | 17-Aug | 21-Aug | 17-Aug | 18-Aug | 18-Aug | 7-Sep |
Thymoglobulin (mg) | No | 50 | 25 | 75 | 75 | 75 |
Creatinine (mg/dL) | 0.7 | 0.7 | 1 | 0.7 | 1 | 1.1 |
- Citation: Kute VB, Patel HV, Varyani UT, Shah PR, Modi PR, Shah VR, Rizvi SJ, Pal BC, Shah PS, Wakhare PS, Ghodela VA, Shinde SG, Trivedi VB, Patel MH, Trivedi HL. Six end-stage renal disease patients benefited from first non-simultaneous single center 6-way kidney exchange transplantation in India. World J Nephrol 2016; 5(6): 531-537
- URL: https://www.wjgnet.com/2220-6124/full/v5/i6/531.htm
- DOI: https://dx.doi.org/10.5527/wjn.v5.i6.531